BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16845331)

  • 1. Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.
    Lim E; Browning J; MacGregor D; Davis ID; Cebon JS
    Melanoma Res; 2006 Aug; 16(4):347-55. PubMed ID: 16845331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy.
    Trefzer U; Hofmann M; Reinke S; Guo YJ; Audring H; Spagnoli G; Sterry W
    Melanoma Res; 2006 Apr; 16(2):137-45. PubMed ID: 16567969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group.
    de Vries TJ; Smeets M; de Graaf R; Hou-Jensen K; Bröcker EB; Renard N; Eggermont AM; van Muijen GN; Ruiter DJ
    J Pathol; 2001 Jan; 193(1):13-20. PubMed ID: 11169510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
    de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
    Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of melanoma-associated antigens in melanoma cell cultures.
    Urosevic M; Braun B; Willers J; Burg G; Dummer R
    Exp Dermatol; 2005 Jul; 14(7):491-7. PubMed ID: 15946236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor antigen expression in melanoma varies according to antigen and stage.
    Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
    Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
    Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.
    Al-Batran SE; Rafiyan MR; Atmaca A; Neumann A; Karbach J; Bender A; Weidmann E; Altmannsberger HM; Knuth A; Jäger E
    Cancer Res; 2005 May; 65(9):3937-41. PubMed ID: 15867394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma or not? Cancer testis antigens may help.
    Lüftl M; Schuler G; Jungbluth AA
    Br J Dermatol; 2004 Dec; 151(6):1213-8. PubMed ID: 15606517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma.
    Syed ON; Mandigo CE; Killory BD; Canoll P; Bruce JN
    J Clin Neurosci; 2012 Jul; 19(7):1016-21. PubMed ID: 22534618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
    Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
    Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
    Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
    Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.
    Sundram U; Harvell JD; Rouse RV; Natkunam Y
    Mod Pathol; 2003 Aug; 16(8):802-10. PubMed ID: 12920225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and molecular analysis of human melanomas for expression of the human cancer-testis antigens NY-ESO-1 and LAGE-1.
    Vaughan HA; Svobodova S; Macgregor D; Sturrock S; Jungbluth AA; Browning J; Davis ID; Parente P; Chen YT; Stockert E; St Clair F; Old LJ; Cebon J
    Clin Cancer Res; 2004 Dec; 10(24):8396-404. PubMed ID: 15623618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procollagen 1 and Melan-A expression in desmoplastic melanomas.
    Leinweber B; Hofmann-Wellenhof R; Kaddu S; McCalmont TH
    Am J Dermatopathol; 2009 Apr; 31(2):173-6. PubMed ID: 19318805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of melanoma inhibitory activity in melanoma and nonmelanoma tissue specimens.
    Perez RP; Zhang P; Bosserhoff AK; Buettner R; Abu-Hadid M
    Hum Pathol; 2000 Nov; 31(11):1381-8. PubMed ID: 11112213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.